Hydrochlorothiazide 50mg tablets — Class II drug recall D-1516-2020
Terminated recall by Calvin Scott & Company, Inc., reported 2020-08-26, distributed nationwide. CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
| Recall number | D-1516-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Calvin Scott & Company, Inc., Albuquerque, NM, United States |
| Recall initiated | 2020-07-27 |
| Classified | 2020-08-20 |
| Reported by FDA | 2020-08-26 |
| Terminated | 2024-04-11 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp |
| NDC | 16729-0184-17 |
| Lot numbers | 10/20, 18252, 19033 |
Product
Hydrochlorothiazide 50mg tablets, 14-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Manufactured by Accord Healthcare, Inc., Durham NC 27703; NDC 16729-0184-17
Reason for recall
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1516-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.